Correction: Aberrant hydroxymethylation in promoter CpG regions of genes related to the cell cycle and apoptosis characterizes advanced chronic myeloid leukemia disease, poor imatinib respondents and poor survival.

Guru, Sameer Ahmad; Sumi, Mamta Pervin; Mir, Rashid; Beg, Mirza Masroor Ali; Koner, Bidhan Chandra; Saxena, Alpana

Guru, Sameer Ahmad; Sumi, Mamta Pervin; Mir, Rashid; Beg, Mirza Masroor Ali; Koner, Bidhan Chandra; Saxena, Alpana.

Afiliação

Guru SA; Lurie Children's Hospital and Stanley Manne Children's Research Institute, Northwestern University, Chicago, IL, USA.
Sumi MP; Department of Biochemistry, Multidisciplinary Research Unit (MRU), Maulana Azad Medical College, New Delhi, India.
Mir R; Department of Inflammation and Immunity, Lerner Research Institute, Cleve Land Clinic OH, Cleveland, USA.
Beg MMA; Kingdom of Saudi Arabia, University of Tabuk, Tabuk, Saudi Arabia.
Koner BC; Faculty of Medicine and Center for Promotion of Medical Research, Faculty of Medical Sciences, Ala-Too International University, Bishek, Kyrgyzstan.
Saxena A; Department of Biochemistry, Hamdard Institute of Medical Science and Research (HIMSR), New Delhi, India.

BMC Cancer ; 22(1): 439, 2022 Apr 22.

Article em En | MEDLINE | ID: mdl-35459155

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article